A Phase 1/2, Open-Label Study Of Pd-1 Knockout Tumor-Infiltrating Lymphocytes (Iov-4001) In Participants With Unresectable Or Metastatic Melanoma Or Stage III Or Iv Non-Small-Cell Lung Cancer
Posted Date: Apr 26, 2024
- Investigator: Trisha Wise-Draper
- Specialties: Cancer, Lung Cancer
- Type of Study: Drug
This is a study to investigate the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung cancer (NSCLC).
Criteria:
Null
Keywords:
Tumor Infiltrating Lymphocytes
For More Information:
Kayla Webb
NULL
cancer@uchealth.com